Lubrizol to Invest $25 Million in Calvert City, KY Facility Expansion
To continue providing dedicated support to its industry partners
CLEVELAND, October 24, 2018 - The Lubrizol Corporation announces it will invest more than $25 million in its Calvert City, Kentucky manufacturing facility, allowing the company to meet increasing customer demand. This investment follows a recent $10 million expansion at the site to further improve the company's safety management standards and create a world class quality laboratory.
The facility specializes in the production of Carbopol® polymers and Pemulen(TM) polymeric emulsifiers. These polymers are used in consumer goods for the personal care, home care, and pharmaceutical markets. This expansion will include advanced, proprietary process technology that will allow the Calvert City facility to continue to provide Lubrizol's partners with high quality products.
"In response to increasing market demand, this investment will enable us to expand production capacity and update our infrastructure at our Calvert City facility while continuously improving safety and quality," states Deb Langer, senior vice president and general manager of Lubrizol Personal, Home and Healthcare. "The expansion is critical in allowing our team to continue to provide dedicated service and support to our global partners."
About Lubrizol Personal and Home Care
We develop, manufacture and market a broad range of specialty chemicals for skin care, hair care, bath and shower, dish care, surface care and fabric care. Our innovative ingredients and additives modify physical properties, enhance functional performance and deliver aesthetic benefits to drive key consumer product claims. Furthermore, with Active Organics' botanical extracts and Lipotec's peptide-based active ingredients, we have strategically expanded our product portfolio and continue to build upon our current capabilities, formulations expertise and global manufacturing footprint to take innovation to the next level. We partner closely with our customers to create winning brands - through our commitment to market intimacy, knowledgeable people, technical expertise and essential, market-driving solutions. Our primary focus is on the needs and demands of our partners on a global basis. We are persistently committed to innovation that directly addresses the market trends and to provide you with powerful, proven solutions so you can Formulate with Confidence(TM).
About Lubrizol LifeSciences
Lubrizol LifeSciences is a preferred Contract Development and Manufacturing Organization (CDMO) partner for complex pharmaceuticals and high-end medical devices providing differentiated polymers and excipients, along with state-of-the-art design, development and manufacturing services to the healthcare industry.
About The Lubrizol Corporation:
The Lubrizol Corporation, a Berkshire Hathaway company, is a market-driven global company that combines complex, specialty chemicals to optimize the quality, performance and value of customers' products while reducing their environmental impact. It is a leader at combining market insights with chemistry and application capabilities to deliver valuable solutions to customers in the global transportation, industrial and consumer markets. Lubrizol improves lives by acting as an essential partner in our customers' success, delivering efficiency, reliability or wellness to their end users. Technologies include lubricant additives for engine oils, driveline and other transportation-related fluids, industrial lubricants, as well as additives for gasoline and diesel fuel. In addition, Lubrizol makes ingredients and additives for home care, personal care and skin care products and specialty materials encompassing polymer and coatings technologies, along with polymer-based pharmaceutical and medical device solutions.
With headquarters in Wickliffe, Ohio, Lubrizol owns and operates manufacturing facilities in 17 countries, as well as sales and technical offices around the world. Founded in 1928, Lubrizol has approximately 8,700 employees worldwide. Revenues for 2017 were $6.3 billion. For more information, visit Lubrizol.com.